Skip to main content
    S

    SkinHealth Systems Inc. (SKIN)

    Official site

    CONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NASDAQ

    $13.88
    -1.17 (-7.81%)

    Market Cap: $106.26M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    SkinHealth Systems Inc. (SKIN) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    SkinHealth Systems (SKIN) has a market cap of $106.26M and an enterprise value of $236.84M. Its net debt of $130.58M equals 122.89% of its market cap.

    Total Valuation

    Enterprise value is 122.89% above the market cap, as debt exceeds cash.

    Market Cap$106.26M
    Enterprise Value$236.84M
    Latest price (Nov 17, 2026)$13.88

    Key Dates

    The next earnings report is expected on Mar 10, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 10, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 94.98% in the quarter ended Sep 30, 2026 and shrank 77.09% a year over 2 years.

    Shares Outstanding6.51M
    Shares Change (YoY)+2.60%
    Shares Change (QoQ)-94.98%
    Share Count Growth (2Y CAGR)-77.09%

    Valuation Ratios

    Sales and book value multiples are 0.3x and 1.6x.

    P/S Ratio0.3x
    Forward P/S0.4x
    P/B Ratio1.6x
    P/FCF Ratio4.0x
    P/OCF Ratio4.5x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 7.0x EBITDA and 9.7x free cash flow.

    EV / Sales0.8x
    EV / EBITDA7.0x
    EV / EBIT36.9x
    EV / FCF9.7x

    Price Statistics

    The stock is down 45.80% over 52 weeks and trades 10.51% above its 50-day average.

    Beta (1Y)1.32
    52-Week Change-45.80%
    1-Month Change+31.52%
    3-Month Change+16.64%
    6-Month Change+4.72%
    5-Year Change-98.19%
    Total Return (1Y)-45.80%
    Total Return (3Y CAGR)-32.54%
    Total Return (5Y CAGR)-52.12%
    Return vs SPY (1Y)-58.60%
    Max Drawdown (1Y)-68.74%
    Max Drawdown (3Y)-89.03%
    Sharpe Ratio (1Y)-0.60
    Correlation with SPY (1Y)0.17
    50-Day Average$12.56
    200-Day Average$15.74
    52-Week Range$9.68 to $33.00
    RSI (14 Days)53.3
    Average Volume (20 Days)78.66K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.89x current liabilities, and total debt is 4.36x shareholder equity.

    Current Ratio2.89x
    Quick Ratio2.22x
    Debt / Equity4.36x
    Debt / EBITDA7.68x
    Debt / FCF10.71x
    Interest Coverage0.25x

    Returns and Efficiency

    Return on invested capital is 2.15% over the last 12 months, against a 5-year average of -2.40%.

    Return on Equity (ROE)-32.81%
    Return on Assets (ROA)-4.70%
    Return on Invested Capital (ROIC)2.15%
    Return on Capital Employed (ROCE)2.01%
    ROE (5Y Average)-67.83%
    ROA (5Y Average)-8.72%
    ROIC (5Y Average)-2.40%
    Asset Turnover0.65x
    Inventory Turnover2.03x
    Receivables Turnover15.98x
    Cash Conversion Cycle142 days

    Scores

    SKIN has an Altman Z-Score of -0.53, in the distress zone below 1.81, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score-0.53
    Altman Z ZoneDistress
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $288.56M over the last 12 months is down 4.42% from the 12 months before.

    Revenue$288.56M
    Revenue Growth (YoY)-4.42%
    Gross Profit$193.96M
    Operating Income$6.91M
    Pretax Income-$13.19M
    Net Income-$18.29M
    EBITDA$31.64M
    EBIT$6.41M
    Reported EPS (TTM)-$0.19

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 14.33% of the $389.06M in total assets.

    Cash and Equivalents$112.39M
    Total Debt$242.96M
    Net Debt$130.58M
    Net Debt Per Share$20.06
    Working Capital$131.75M
    Shareholder Equity$55.76M
    Book Value Per Share$8.56
    Tangible Book Value-$97.98M
    Total Assets$389.06M
    Total Liabilities$333.31M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $883.00K of capital spending, operating cash flow left $22.69M of free cash flow.

    Operating Cash Flow$23.58M
    Capital Expenditures$883.00K
    Free Cash Flow$22.69M
    FCF Per Share$3.48
    Depreciation and Amortization$25.23M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 2.39%, against a 5-year average of -16.50%.

    Gross Margin67.22%
    Operating Margin2.39%
    Pretax Margin-4.57%
    Net Margin-6.34%
    EBITDA Margin10.97%
    EBIT Margin2.22%
    FCF Margin7.86%
    Gross Margin (5Y Average)59.09%
    Operating Margin (5Y Average)-16.50%
    Net Margin (5Y Average)-34.11%

    Growth

    Revenue fell 6.32% a year over 3 years, and EPS 7.17% a year.

    Revenue Growth (3Y CAGR)-6.32%
    Revenue Growth (5Y CAGR)+20.36%
    EPS Growth (3Y CAGR)-7.17%
    Book Value Per Share Growth (2Y CAGR)+1.90%

    Revenue and profit by year

    Dividends and Yields

    SKIN does not pay a dividend. Its free cash flow yield is 25.12%.

    FCF Yield25.12%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 1-for-20 reverse split on Oct 14, 2026.

    Last Split DateOct 14, 2026
    Split TypeReverse split
    Split Ratio1:20

    Peer Position

    Against 11 similar companies, SKIN has the 8th highest P/S.

    P/S Ratio0.3x vs 1.1x median
    ROIC2.15% vs 2.47% median
    Revenue Growth (Trailing 4 Quarters, YoY)-4.42% vs -1.95% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -2.00% and EPS growth at 958.30% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-2.00%
    EPS Growth Forecast (2Y CAGR)+958.30%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About SKIN

    What is SKIN's market cap?

    SkinHealth Systems has a market cap of $106.26M. Its enterprise value, which adds debt and subtracts cash, is $236.84M.

    How many shares of SKIN are outstanding?

    SkinHealth Systems has 6.51M shares outstanding. The count is up 2.60% from a year earlier.

    Does SKIN pay a dividend?

    No. SkinHealth Systems does not pay a dividend.

    How much debt does SKIN have?

    SkinHealth Systems has $242.96M of total debt and $112.39M of cash and equivalents, a net debt position of $130.58M.